These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 26337512)

  • 1. Transcriptional regulation of myeloid-derived suppressor cells.
    Condamine T; Mastio J; Gabrilovich DI
    J Leukoc Biol; 2015 Dec; 98(6):913-22. PubMed ID: 26337512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor metastasis by myeloid-derived suppressor cells.
    Condamine T; Ramachandran I; Youn JI; Gabrilovich DI
    Annu Rev Med; 2015; 66():97-110. PubMed ID: 25341012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
    Ye XZ; Yu SC; Bian XW
    J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intertwined regulation of angiogenesis and immunity by myeloid cells.
    Rivera LB; Bergers G
    Trends Immunol; 2015 Apr; 36(4):240-9. PubMed ID: 25770923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell-deficient Kit(W-sh) "Sash" mutant mice display aberrant myelopoiesis leading to the accumulation of splenocytes that act as myeloid-derived suppressor cells.
    Michel A; Schüler A; Friedrich P; Döner F; Bopp T; Radsak M; Hoffmann M; Relle M; Distler U; Kuharev J; Tenzer S; Feyerabend TB; Rodewald HR; Schild H; Schmitt E; Becker M; Stassen M
    J Immunol; 2013 Jun; 190(11):5534-44. PubMed ID: 23636054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-induced systemic myeloid dysfunction: Implications for treatment and a novel nanoparticle approach for its correction.
    Alvarez R; Oliver L; Valdes A; Mesa C
    Semin Oncol; 2018 Jan; 45(1-2):84-94. PubMed ID: 30318088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-Derived Suppressor Cells and Proinflammatory Cytokines as Targets for Cancer Therapy.
    Atretkhany KN; Drutskaya MS
    Biochemistry (Mosc); 2016 Nov; 81(11):1274-1283. PubMed ID: 27914453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells in parasitic infections.
    Van Ginderachter JA; Beschin A; De Baetselier P; Raes G
    Eur J Immunol; 2010 Nov; 40(11):2976-85. PubMed ID: 21061431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cell heterogeneity in human cancers.
    Solito S; Marigo I; Pinton L; Damuzzo V; Mandruzzato S; Bronte V
    Ann N Y Acad Sci; 2014 Jun; 1319():47-65. PubMed ID: 24965257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNAs as potential regulators of myeloid-derived suppressor cell expansion.
    El Gazzar M
    Innate Immun; 2014 Apr; 20(3):227-38. PubMed ID: 23757323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of metabolism-driven myeloid dysfunctions in cancer therapy.
    Strauss L; Guarneri V; Gennari A; Sica A
    Cell Mol Immunol; 2021 Apr; 18(4):829-841. PubMed ID: 33077904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Myeloid Cells in Cancer: The Spleen Matters.
    Wu C; Hua Q; Zheng L
    Front Immunol; 2020; 11():1126. PubMed ID: 32582203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
    Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
    Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.
    Marvel D; Gabrilovich DI
    J Clin Invest; 2015 Sep; 125(9):3356-64. PubMed ID: 26168215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factors in myeloid-derived suppressor cell recruitment and function.
    Sonda N; Chioda M; Zilio S; Simonato F; Bronte V
    Curr Opin Immunol; 2011 Apr; 23(2):279-85. PubMed ID: 21227670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.
    Saleem SJ; Conrad DH
    Int Immunopharmacol; 2011 Jul; 11(7):808-15. PubMed ID: 21426948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
    Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
    J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Brief: Myeloid-derived suppressor cells in cancer.
    Solito S; Pinton L; Mandruzzato S
    J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy.
    Messmer MN; Netherby CS; Banik D; Abrams SI
    Cancer Immunol Immunother; 2015 Jan; 64(1):1-13. PubMed ID: 25432147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.